Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$888,140
-$166,732 QoQ
Shares Held
74,446
-11.6% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 94.21728501195497.ToString("F0")%
Shared 0.ToString("F0")%
None 5.782714988045027.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SECTORAL ASSET MANAGEMENT INC holds $59,224,680 across 45 Biotechnology names. TRVI ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EVMN |
Evommune, Inc.
|
589,005 | $13,541,224 | |
| 2 | CTNM |
Contineum Therapeutics, Inc.
|
727,587 | $9,502,286 | |
| 3 | INSM |
INSMED Inc
|
19,668 | $3,216,111 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,007 | $3,128,905 | |
| 5 | ARGX |
Argenx SE
|
3,564 | $2,602,611 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,919 | $2,255,336 | |
| 7 | BNTX |
BioNTech SE
|
22,164 | $1,969,936 | |
| 8 | SMMT |
Summit Therapeutics Inc.
|
69,615 | $1,319,900 |
All Filings in TRVI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $888,140 | 74,446 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,054,872 | 84,255 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $969,442 | 105,950 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $733,800 | 134,150 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $514,522 | 81,800 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||